Malyngamide X: The first (7R)-lyngbic acid that connects to a new tripeptide backbone from the Thai sea hare Bursatella leachii

Chemistry - An Asian Journal

Volumn 2, Issue 1, 2007, Pages 114-122

  Suntornchashwej, Suchada ^a,b   Suwanborirux, Khanit ^a   Koga, Kazushi ^b   Isobe, Minoru ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Chiral resolution; Chiral solvating agent; Malyngamide X; Natural products; Sea hare

Indexed keywords

ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; CARBOXYLIC ACID; MALYNGAMIDE X; OLIGOPEPTIDE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG SENSITIVITY; GASTROPOD; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM FALCIPARUM; STEREOISOMERISM; THAILAND; TUMOR CELL LINE;

ANIMALS; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; ANTITUBERCULAR AGENTS; CARBOXYLIC ACIDS; CELL LINE, TUMOR; CELL SURVIVAL; GASTROPODA; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; OLIGOPEPTIDES; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; STEREOISOMERISM; THAILAND;

EID: 33846279757     PISSN: 18614728     EISSN: 1861471X     Source Type: Journal    
DOI: 10.1002/asia.200600219     Document Type: Article

References (48)

1. A. M. Burja, B. Banaigs, E. Abou-Mansour, J. G. Burgess, P. C. Wright, Tetrahedron 2001, 57, 9347-9377.
2. K. L. McPhail, W. H. Gerwick, J. Nat. Prod. 2003, 66, 132-135.
3. D. R. Appleton, M. A. Sewell, M. V. Berridge, B. R. Copp, J. Nat. Prod. 2002, 65, 630-631.
4. Compound 3 is the major fatty acid substructure in malyngamides; for a review, see reference [1]; a) L. T. Tan, T. Okino, W. H. Gerwick, J. Nat. Prod. 2000, 63, 952-955;
5. b) L. M. Nogle, W. H. Gerwick, J. Nat. Prod. 2003, 66, 217-220;
6. c) K. E. Milligan, B. Márquez, R. T. Williamson, M. Davies-Coleman, W. H. Gerwick, J. Nat. Prod. 2000, 63, 965-968;
7. d) Y. Kan, B. Sakamoto, T. Fujita, H. Nagai, J. Nat. Prod. 2000, 63, 1599-1602.
8. a) J. S. Mynderse, R. E. Moore, J. Org. Chem. 1978, 43, 4359-4363;
9. b) W. H. Gerwick, S. Reyes, B. Alvarado, Phytochemistry 1978, 17, 1701-1704.
10. F. Wan, K. L. Erickson, J. Nat. Prod. 1999, 62, 1696-1699.
11. W. Gallimore, P. J. Scheuer, J. Nat. Prod. 2000, 63, 1422-1424.
12. S. Suntornchashwej, N. Chaichit, M. Isobe, K. Suwanborirux, J. Nat. Prod. 2005, 68, 951-955.
13. The tripeptide moiety 1 was numbered with respect to the neurotoxin janolusimide (6), a very similar tripeptide; a) G. Sodano, A. Spinella, Tetrahedron Lett. 1986, 27, 2505-2508;
14. b) A. Giordano, A. Spinella, G. Sodano, Tetrahedron: Asymmetry 1999, 10, 1851-1854;
15. c) A. Giordano, C. D. Monica, F. Landi, A. Spinella, G. Sodano, Tetrahedron Lett. 2000, 41, 3979-3982.
16. J. H. Cardellina, D. Dalietos, F.-J. Marner, J. S. Mynderse, R. E. Moore, Phytochemistry 1978, 17, 2091-2095.
17. D. L. Boger, H. Cai, Angew. Chem. 1999, 111, 470-500;
18. Angew. Chem. Int. Ed. 1999, 38, 448-476.
19. 3- pyrrolin-2-one, see: B. J. L. Royles, Chem. Rev. 1995, 95, 1981-2001.
20. H,H = 0-4 Hz); a) C. H. Heathcock, M. C. Pirrung, J. E. Sohn, J. Org. Chem. 1979, 44, 4294-4299;
21. b) S. Paik, S. Carmeli, J. Cullingham, R. E. Moore, G. M. L. Patterson, M. A. Tius, J. Am. Chem. Soc. 1994, 116, 8116-8125.
22. H,H is a value typical for an anti configuration, the NOE analysis should be reliable, as no significant conformational change takes place; N. Matsumori, D. Kaneno, M. Murata, H. Nakamura, K. Tachibana, J. Org. Chem. 1999, 64, 866-876. (Chemical Equation Presented)
23. I. Ohtani, T. Kusumi, Y. Kashman, H. Kakisawa, J. Am. Chem. Soc. 1991, 113, 4092-4096.
24. The method pioneered by Pirkle and Beare follows from the possibility of relating the sense of chemical shift nonequivalence (upfield vs. downfield of a signal) for one enantiomer of a compound dissolved in an optically active solvent; see, for instance: a) W. H. Pirkle, S. D. Beare, J. Am. Chem. Soc. 1969, 91, 5150-5155;
25. b) W. H. Pirkle, C. W. Boeder, J. Org. Chem. 1977, 42, 3697-3700;
26. c) D. Parker, Chem. Rev. 1991, 91, 1441-1457;
27. d) T. J. Wenzel, J. D. Wilcox, Chirality 2003, 15, 256-270.
28. There are very few reports about the use of CSAs for absolute configuration assignment; a) S. Latypov, X. Franck, J.-C. Jullian, R. Hocquemiller, B. Figadére, Chem. Eur. J. 2002, 8, 5662-5666;
29. b) J.-C. Jullian, X. Franck, S. Latypov, R. Hocquemiller, B. Figadére, Tetrahedron: Asymmetry 2003, 14, 963-966;
30. c) R. Stipanovic, J. P. McCormick, E. O. Schlemper, B. C. Hamper, T. Shinmyozu, W. H. Pirkle, J. Org. Chem. 1986, 51, 2500-2504.
31. RS values were thus the average shifts of the signals of the diastereomeric complexes that rapidly equilibrate with the bulk of cosolvent on the NMR timescale.
32. K. Akaji, Y. Hayashi, Y. Kiso, N. Kuriyama, J. Org. Chem. 1999, 64, 405-411.
33. For absolute configuration assignment with aid from conformational calculations, see, for example: a) M. Ubutaka, X.-C. Cheng, M. Isobe, K. Isono, J. Chem. Soc. Perkin Trans. 1 1993, 617-624;
34. b) H. Luesch, W. Y. Yoshida, R. E. Moore, V. J. Paul, T. H. Corbett, J. Am. Chem. Soc. 2001, 123, 5418-5423;
35. c) R. T. Williamson, A. Boulanger, A. Vulpanovici, M. A. Roberts, W. H. Gerwick, J. Org. Chem. 2002, 67, 7927-7936;
36. d) P. G. Williams, W. Y. Yoshida, M. K. Quon, R. E. Moore, V. J. Paul, J. Nat. Prod. 2003, 66, 651-654.
37. 3 and 8-H.
38. The biosynthetic considerations have recently been employed to solve the stereochemistry of C7′; see: Y. Kan, T. Fujita, H. Nagai, B. Sakamoto, Y. Hokama, J. Nat. Prod. 1998, 61, 152-155, and reference [7].
39. D = -15.4 (c = 0.8, MeOH). This difference must be due to the large distance between the C7′ stereogenic center and the other five stereogenic centers in the tripeptide portion. The consistent result in the NMR chiral solvation experiments was obtained with synthetic (7′R)-1. The details for the total synthesis of both (7′R)- and (7′S)-malyngamide X and the NMR chiral solvation experiments will be reported elsewhere.
40. V. Mesguiche, R. Valls, L. Piovetti, G. Peiffer, Tetrahedron Lett. 1999, 40, 7473-7476.
41. M. Wu, K. E. Milligan, W. H. Gerwick, Tetrahedron 1997, 53, 15 983-15 990.
42. D measurements.
43. N. M. Carballeira, M. Pagán, J. Nat. Prod. 2001, 64, 620-623.
44. M. A. Walker, C. H. Heathcock, J. Org. Chem. 1991, 56, 5747-5750.
45. L. Collins, S. G. Franzblau, Antimicrob. Agents Chemother. 1997, 41, 1004-1009.
46. a) W. Trager, J. B. Jensen, Science 1976, 193, 673-675;
47. b) R. E. Desjardins, C. J. Canfield, J. D. Haynes, J. D. Chulay, Antimicrob. Agents Chemother. 1979, 16, 710-718.
48. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyd, J. Natl. Cancer Inst. 1990, 82, 1107-1112.